SMT201600381B - Composizioni farmaceutiche ad attività antibatterica e cicatrizzante - Google Patents

Composizioni farmaceutiche ad attività antibatterica e cicatrizzante

Info

Publication number
SMT201600381B
SMT201600381B SM201600381T SM201600381T SMT201600381B SM T201600381 B SMT201600381 B SM T201600381B SM 201600381 T SM201600381 T SM 201600381T SM 201600381 T SM201600381 T SM 201600381T SM T201600381 B SMT201600381 B SM T201600381B
Authority
SM
San Marino
Prior art keywords
cicatrizing
antibacterial
activities
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
SM201600381T
Other languages
English (en)
Italian (it)
Inventor
Giampaolo Menon
Giovanni Gennari
Susi Panfilo
Original Assignee
Fidia Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici filed Critical Fidia Farmaceutici
Publication of SMT201600381B publication Critical patent/SMT201600381B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SM201600381T 2010-11-19 2016-10-26 Composizioni farmaceutiche ad attività antibatterica e cicatrizzante SMT201600381B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD2010A000349A IT1402786B1 (it) 2010-11-19 2010-11-19 Composizioni farmaceutiche ad attivita' antibatterica e cicatrizzante

Publications (1)

Publication Number Publication Date
SMT201600381B true SMT201600381B (it) 2017-01-10

Family

ID=43742908

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600381T SMT201600381B (it) 2010-11-19 2016-10-26 Composizioni farmaceutiche ad attività antibatterica e cicatrizzante

Country Status (15)

Country Link
US (1) US9265793B2 (enExample)
EP (1) EP2640401B1 (enExample)
JP (1) JP6092781B2 (enExample)
CN (1) CN103249419B (enExample)
AU (1) AU2011330855B2 (enExample)
BR (1) BR112013012120A2 (enExample)
CA (1) CA2815810C (enExample)
ES (1) ES2588397T3 (enExample)
IL (1) IL226220A (enExample)
IT (1) IT1402786B1 (enExample)
MX (1) MX2013005593A (enExample)
RU (1) RU2611046C2 (enExample)
SI (1) SI2640401T1 (enExample)
SM (1) SMT201600381B (enExample)
WO (1) WO2012066447A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2978664B1 (fr) * 2011-08-04 2014-01-10 Petcare Innovation Composition antiseptique
CN103191461B (zh) * 2013-04-26 2015-09-16 华熙福瑞达生物医药有限公司 一种含透明质酸的伤口护理用敷料
ITMI20130883A1 (it) * 2013-05-30 2014-12-01 Eurores S R L Composizioni farmaceutiche comprendenti collagene e sodio ialuronato
US20150064129A1 (en) * 2013-09-04 2015-03-05 Taiwan Biotech Co., Ltd. Wound healing composition
CN116669717A (zh) * 2020-08-17 2023-08-29 美国人福制药公司 长效原位成型/胶凝组合物
TWI823516B (zh) * 2022-08-10 2023-11-21 鈺永科技有限公司 由有機鍺化合物和葡萄糖胺化合物製備的藥物及其用途
TWM680381U (zh) * 2024-12-24 2026-02-21 聿健生物科技股份有限公司 敷料製造裝置及敷料產品

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005517A1 (en) * 1986-03-14 1987-09-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid useful as antimicrobial agents
IT1263394B (it) * 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
IT1281877B1 (it) * 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
IT1317359B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
JP2002173405A (ja) * 2000-12-04 2002-06-21 Hidehiro Tagusari コロイド銀による殺菌方法及びこれを用いた殺菌処理材
AU2003263344B2 (en) * 2002-09-11 2009-01-08 Johnson & Johnson Medical Limited Wound dressing materials comprising complexes of anionic polysaccharides with silver
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
DE10340277B4 (de) * 2003-08-29 2006-11-23 Bio-Gate Bioinnovative Materials Gmbh Körperpflegemittel mit Silber-Agglomeraten
WO2005032417A2 (en) * 2003-09-30 2005-04-14 Synthes (Usa) Antimicrobial hyaluronic acid coatings for orthopedic implants
US20050112151A1 (en) * 2003-11-20 2005-05-26 Horng Liou L. Skin adherent hydrogels
CN101001649B (zh) * 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
DE102005008299B4 (de) 2005-02-23 2025-07-10 Bio-Gate Ag Kosmetische und/oder dermatologische Formulierung, Verfahren zu deren Herstellung und Verwendung der Formulierung
US20100113871A1 (en) * 2006-09-13 2010-05-06 Aylvin Jorge Angelo Athanasius Dias Antimicrobial coating
DE102007044582A1 (de) * 2007-09-19 2009-04-09 Deckner, Peter G., Dr. med. Zusammensetzung für Wundbehandlungen im Humanbereich
DE102007044583A1 (de) * 2007-09-19 2009-04-09 Deckner, Peter G., Dr. med. Zusammensetzung für Wundbehandlungen im Veterinärbereich
DE102008031023A1 (de) * 2008-06-30 2009-12-31 Neubourg Skin Care Gmbh & Co. Kg Schaumhautpflegecreme
EP2218447B1 (en) 2008-11-04 2017-04-19 PharmaSol GmbH Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles
WO2010127647A1 (de) * 2009-05-08 2010-11-11 Deckner Peter G Zusammensetzungen für wundbehandlungen im human-, und veterinärbereich

Also Published As

Publication number Publication date
AU2011330855B2 (en) 2016-09-15
US20130230594A1 (en) 2013-09-05
RU2611046C2 (ru) 2017-02-20
CA2815810C (en) 2018-10-30
ITPD20100349A1 (it) 2012-05-20
CN103249419B (zh) 2016-11-02
WO2012066447A1 (en) 2012-05-24
IL226220A0 (en) 2013-07-31
BR112013012120A2 (pt) 2016-09-27
IT1402786B1 (it) 2013-09-18
US9265793B2 (en) 2016-02-23
EP2640401A1 (en) 2013-09-25
RU2013127673A (ru) 2014-12-27
CA2815810A1 (en) 2012-05-24
JP2014500257A (ja) 2014-01-09
SI2640401T1 (sl) 2017-02-28
IL226220A (en) 2017-12-31
ES2588397T3 (es) 2016-11-02
AU2011330855A1 (en) 2013-05-23
MX2013005593A (es) 2013-09-26
JP6092781B2 (ja) 2017-03-08
CN103249419A (zh) 2013-08-14
EP2640401B1 (en) 2016-07-20

Similar Documents

Publication Publication Date Title
SMT201700008B (it) Composizione farmaceutica
SMT201600350B (it) Composizioni farmaceutiche
DK3246018T3 (da) Farmaceutisk sammensætning
BR112012031855A2 (pt) composição e artigo
PL2611310T3 (pl) Formulacja antybakteryjna
EP2549993A4 (en) ANTIMICROBIAL COMPOSITIONS
PL2424372T3 (pl) Kompozycje przeciwdrobnoustrojowe i powiązane sposoby zastosowania
BR112012027165A2 (pt) composição e artigo
BR112013023776A2 (pt) composição e abertura vedada com selante
EE201300005A (et) Ravimkoostis
BR112013014644A2 (pt) composição farmacêutica e complexo
HRP20160922T1 (hr) Oligopeptidni spojevi i njihove uporabe
BR112013010694A2 (pt) composições antitranspirantes ativas e sua produção
FI20115816L (fi) Antimikrobinen ionomeerikoostumus sekä sen käyttösovellukset
BR112013010074A2 (pt) composição celulósica e produto
EP2568987A4 (en) TETRACYCLINE COMPOSITIONS
EP2635269A4 (en) COMBINATION COMPOSITION
EP2627172A4 (en) ANTIMICROBIAL COMPOSITION
CO6801722A2 (es) Composiciones farmacéuticas
BR112013008074A2 (pt) combinações farmacêuticas
BR112012000383A2 (pt) composições farmacêuticas e formas sólidas
IT1402786B1 (it) Composizioni farmaceutiche ad attivita' antibatterica e cicatrizzante
EP2581400A4 (en) Polyamide and polyamide composition
EP2605654A4 (en) ANTIMICROBIAL COMPOSITIONS
BR112015002646A2 (pt) composto e composição farmacêutica